PCNA and breast carcinoma: Downregulation of p21 by miR-17-5p in turn promotes PCNA (proliferating cell nuclear antigen) activity, where p21 is a negative regulator of PCNA and thus ERα promotes breast cancer cell cycle progression and proliferation in p21/PCNA/E2F1-dependent pathway [68].